Psychedelics are a hallucinogenic class of psychoactive drugs with the primary effect of
activating non-ordinary states of consciousness. Due to the positive preliminary findings of these …

Multiple lines of evidence have implicated brain-derived neurotrophic factor (BDNF) in
treatment-resistant depression (TRD). The aim of this synthesis was to determine the impact of …

Ketamine is a promising therapeutic option in treatment-resistant depression (TRD). The
acute efficacy of ketamine in TRD has been demonstrated in replicated randomised-controlled …

Background Few studies have evaluated the efficacy of ketamine-assisted psychotherapy (KAP)
in the treatment of treatment-resistant depression (TRD) and substance use disorders (…

Ketamine is a dissociative anesthetic used worldwide for anesthesia, pain management,
treatment resistant depression (TRD) and suicidality. Predictors of antidepressant response and …

Pediatric depression is a common psychiatric disorder that is associated with significant
morbidity and mortality. Ketamine is a non-competitive N-methyl-D-aspartate (NMDA) receptor …

Objective Ketamine has demonstrated rapid and significant antidepressant effects in patients
with treatment resistant depression (TRD). Herein, we conducted a systematic review to …

Psychiatric and metabolic disorders are highly comorbid and the relationship between these
disorders is bidirectional. The mechanisms underlying the association between psychiatric …

Objectives: Ketamine is a glutamate N-methyl-D-aspartate receptor antagonist that can be
used to treat major depressive disorder by single or repeated infusions. However, the …

Major depressive disorder (MDD) is a common mental disorder with a high rate of morbidity
and mortality. Dysfunctional signaling of gamma-aminobutyric acid (GABA) has been …